載入...
Bevacizumab for Glioblastoma—A Promising Drug or Not?
Two double blind, placebo-controlled, and randomized phase III studies were conducted, and the results including OS’s were reported at the ASCO Meeting in June 2013, which was the beginning of confusion surrounding this topic. This is a review article not only summarizing the previous evidence, but...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3875948/ https://ncbi.nlm.nih.gov/pubmed/24213559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers5041456 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|